Market Closed

RLMD
Relmada Therapeutics
$ 4.21
1.20%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

Relmada Therapeutics News

Latest Relmada Therapeutics Stock News & RLMD Headlines

What Relmada Therapeutics (RLMD) Said on Its Q3 Earnings Call
3 days ago | marketbeat.com
Relmada Therapeutics, Inc. (RLMD) Q3 2026 Earnings Call Transcript
3 days ago | seekingalpha.com
Relmada Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
3 days ago | globenewswire.com
Relmada Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, November 12, 2026
13 days ago | globenewswire.com
Relmada Therapeutics, Inc. (NASDAQ:RLMD) Stock Has Consensus Target Price of $12.00
a month ago | defenseworld.net
812,059 Shares in Relmada Therapeutics, Inc. $RLMD Purchased by Bank of America Corp DE
2 months ago | defenseworld.net
Relmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference
2 months ago | globenewswire.com
After Plunging 18.5% in 4 Weeks, Here's Why the Trend Might Reverse for Relmada Therapeutics (RLMD)
3 months ago | zacks.com
Here's Why Relmada Therapeutics (RLMD) Is a Great 'Buy the Bottom' Stock Now
3 months ago | zacks.com
Down 29.6% in 4 Weeks, Here's Why Relmada Therapeutics (RLMD) Looks Ripe for a Turnaround
3 months ago | zacks.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

RLMD
Relmada Therapeutics
$ 4.21
1.20%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago